www.hivandhepatitis.com

Other Infections

EASL 2017: Norfloxacin Reduces Risk of Death for People with Decompensated Cirrhosis

Details
Category: Liver Decompensation
Published on Saturday, 22 April 2017 00:00
Written by Keith Alcorn
  • Print

Long-term prophylaxis with the antibiotic norfloxacin significantly reduced the incidence of death in people with decompensated cirrhosis over a 6-month follow-up period, according to a French randomized trial reported at the EASL International Liver Congress this week in Amsterdam.

alt

Read more:

DDW 2014 and EASL 2014: Rifaximin May Be Beneficial for People with Advanced Liver Cirrhosis

Details
Category: Liver Decompensation
Published on Sunday, 18 May 2014 00:00
Written by Liz Highleyman
  • Print

The antibiotic rifaximin may help prevent or improve hepatic encephalopathy and bleeding varices in people with decompensated liver disease, according to studies presented at the recent EASL International Liver Congress and Digestive Disease Week.

alt

Read more:

Copyright © 2023 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design